Abbott to Buy Cancer-Screener Exact Sciences for $21 Billion

{# Share Buttons Partial Variables: share_title — text to pre-fill in share dialogs share_url — canonical URL to share (use request.build_absolute_uri in parent) #}

Market Intelligence Analysis

AI-Powered
Why This Matters

Abbott Laboratories is set to acquire Exact Sciences Corp. in a $21 billion deal, expanding its presence in the cancer-screening market.

Market Impact

Market impact analysis based on bullish sentiment with 70% confidence.

Sentiment
Bullish
AI Confidence
70%

Article Context

Note: This is a brief excerpt for context. Click below to read the full article on the original source.

Abbott Laboratories agreed to acquire cancer-screening company Exact Sciences Corp., in a deal with a total equity value of about $21 billion.

Continue Reading
Full article on Bloomberg
Read Full Article
Original article published by Bloomberg on November 20, 2025.
Analysis and insights provided by AnalystMarkets AI.